North America Gene Synthesis Market By Method, By Service Type, By Application, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The North America Gene Synthesis Market is expected to witness market growth of 17.7% CAGR during the forecast period (2021-2027).

Gene synthesis is a technique that is included in synthetic biology which is being utilized with the purpose of developing artificial genes while incorporating with laboratory standards. It is widely being used for the production of fusion proteins, cloning molecules, or with the purpose to attain higher protein expression.

The number of people that are adopting gene therapy has increased the number of equipment that are required to perform gene therapy. Also, the treatment of infectious diseases requires advanced and special gene therapy equipment to offer impeccable and flawless gene sequences in a reduced time period to offer absolutely enhanced therapy outcomes which is expected to  improve the development of gene synthesis therapy further.

According to the National Institute of Health (NIH) of the United States, synthetic biology is considered as a method for the faster development of various vaccines and to cure distinct genetic disorders. Hence, these factors are anticipated to fuel the growth of the gene synthesis market in the region during the forecasting period.

The US market dominated the North America Gene Synthesis Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $1,515.1 million by 2027. The Canada market is expected to witness a CAGR of 20.4% during (2021 - 2027). Additionally, The Mexico market is expected to experience a CAGR of 19.4% during (2021 - 2027).

Based on Method, the market is segmented into Solid-phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis. Based on Service Type, the market is segmented into Antibody DNA Synthesis, Viral DNA Synthesis and Others. Based on Application, the market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis and Others. Based on End User, the market is segmented into Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies and Contract Research Organizations. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Method

• Solid-phase Synthesis
• Chip-based Synthesis and
• PCR-based Enzyme Synthesis

By Service Type

• Antibody DNA Synthesis
• Viral DNA Synthesis and
• Others

By Application

• Gene & Cell Therapy Development
• Vaccine Development
• Disease Diagnosis and
• Others

By End User

• Academic & Government Research Institutes
• Biotechnology & Pharmaceutical Companies and
• Contract Research Organizations

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Genscript Biotech Corporation
• Thermo Fisher Scientific, Inc.
• Brooks Automation, Inc.
• Boster Biological Technology
• Twist Bioscience Corporation
• Danaher Corporation
• Biomatik Corporation
• ProteoGenix
• ProMab Biotechnologies, Inc.
• OriGene Technologies, Inc.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free